From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa Zodwa DlaminiThulo MolefiRodney Hull Editorial Open access 01 November 2023 Pages: 1 - 11
Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate? Heidi KoRebecca A. PrevisKamal S. Saini Editorial Open access 14 November 2023 Pages: 13 - 17
Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely? Elisa AgostinettoLuca AreccoEvandro de Azambuja Commentary Open access 21 November 2023 Pages: 19 - 29
Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies Gere S. diZeregaHolly A. MaulhardtMarc A. Iacobucci Review Open access 30 January 2024 Pages: 31 - 55
Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation Xavier Thomas Review Open access 01 February 2024 Pages: 57 - 72
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience Francesco PepeGianluca RussoGiancarlo Troncone Original Research Open access 11 January 2024 Pages: 73 - 95
Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK Pauline FrankAnne OlshanEmma Sasse Original Research Open access 07 December 2023 Pages: 97 - 114
Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia Dany HabrManmohan SinghRoberto Uehara Original Research Open access 08 December 2023 Pages: 115 - 129
Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors Hong ChenYan WenNa Xu Original Research Open access 16 December 2023 Pages: 131 - 145
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario Giuseppe Di LorenzoAieta MicheleCarlo Buonerba Original Research Open access 19 December 2023 Pages: 147 - 155
Acute Thrombocytopenia Complicating the Initial Administration of Obinutuzumab: Is It More Frequent Than We Think? Umut YılmazSelin KüçükyurtAhmet Emre Eşkazan Case Series Open access 22 January 2024 Pages: 157 - 161
Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer Giulio MetroEleonora GariazzoGianluigi Lunardi Case Report Open access 16 November 2023 Pages: 163 - 171
Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer Giulio MetroEleonora GariazzoGianluigi Lunardi Correction Open access 03 January 2024 Pages: 173 - 174
Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab Reyes BernabéStephen V. LiuMiriam Alonso García Case Report Open access 27 January 2024 Pages: 175 - 182
Long Term Remission of Capillary Leak Syndrome Associated with Monoclonal Gammopathy with Progression to Multiple Myeloma After Autologous Stem Cell Transplantation: a Case Report and Review of the Literature Gerardo HermidaRodolfo Alvarez-NuñoTomás José González-López Case Report Open access 02 February 2024 Pages: 183 - 188